151 related articles for article (PubMed ID: 6091941)
21. Association of changes in lysophosphatidylcholine metabolism and in microsomal membrane lipid composition to the pulmonary injury induced by oleic acid.
Casals C; Herrera L; Garcia-Barreno P; Municio AM
Biochim Biophys Acta; 1990 Apr; 1023(2):290-7. PubMed ID: 2328251
[TBL] [Abstract][Full Text] [Related]
22. Modification of heart sarcolemmal phosphoinositide pathway by lysophosphatidylcholine.
Liu SY; Yu CH; Hays JA; Panagia V; Dhalla NS
Biochim Biophys Acta; 1997 Nov; 1349(3):264-74. PubMed ID: 9434141
[TBL] [Abstract][Full Text] [Related]
23. Organization and function of sarcolemmal phospholipids in control and ischemic/reperfused cardiomyocytes.
Post JA; Verkleij AJ; Langer GA
J Mol Cell Cardiol; 1995 Feb; 27(2):749-60. PubMed ID: 7776380
[TBL] [Abstract][Full Text] [Related]
24. Role of sarcolemmal-bound calcium in regulation of myocardial contractile force.
Langer GA
J Am Coll Cardiol; 1986 Jul; 8(1 Suppl A):65A-68A. PubMed ID: 3711545
[TBL] [Abstract][Full Text] [Related]
25. Hydrocarbon chain length-dependent antagonism of acylcarnitines to the depressant effect of lysophosphatidylcholine on cardiac sodium current.
Sato T; Ishida H; Nakazawa H; Arita M
J Mol Cell Cardiol; 1996 Oct; 28(10):2183-94. PubMed ID: 8930813
[TBL] [Abstract][Full Text] [Related]
26. Thermodynamic interpretation of effects of alcohols on membrane lipid fluidity.
Boigegrain RA; Fernandez Y; Massol M; Mitjavila S
Chem Phys Lipids; 1984 Oct; 35(4):321-30. PubMed ID: 6094034
[TBL] [Abstract][Full Text] [Related]
27. Fluidity and osmotic sensitivity changes of phospholipase A2-treated liposomes.
Kinjo M; Araiso T; Koyama T
Biorheology; 1988; 25(3):517-25. PubMed ID: 3250632
[TBL] [Abstract][Full Text] [Related]
28. A new approach to the development of anti-ischemic drugs. Substances that counteract the deleterious effect of lysophosphatidylcholine on the heart.
Hashizume H; Hoque AN; Magishi K; Hara A; Abiko Y
Jpn Heart J; 1997 Jan; 38(1):11-25. PubMed ID: 9186278
[TBL] [Abstract][Full Text] [Related]
29. Membrane phospholipid and fatty acid changes in the mitochondrial and sarcolemmal fractions of the heart in adjuvant arthritic rats.
Nemecz G; Bor P; Leprán I; Koltai M; Szekeres L
J Mol Cell Cardiol; 1986 Jul; 18(7):739-47. PubMed ID: 3746921
[TBL] [Abstract][Full Text] [Related]
30. Effects of palmitoyl carnitine and structural analogs on arterial blood pressure in the rat. A comparison with platelet-activating factor.
Man RY; Hu WM; Mock T; Kinnaird AA
J Lipid Mediat; 1991; 3(2):205-14. PubMed ID: 1686730
[TBL] [Abstract][Full Text] [Related]
31. Membrane changes induced by early myocardial ischemia in the dog.
Vasdev SC; Biro GP; Narbaitz R; Kako KJ
Can J Biochem; 1980 Oct; 58(10):1112-9. PubMed ID: 7459675
[TBL] [Abstract][Full Text] [Related]
32. The effect of sarcolemmal cholesterol content on intracellular calcium ion concentration in cultured cardiomyocytes.
Bastiaanse EM; Atsma DE; Kuijpers MM; Van der Laarse A
Arch Biochem Biophys; 1994 Aug; 313(1):58-63. PubMed ID: 8053687
[TBL] [Abstract][Full Text] [Related]
33. The effects of myocardial ischemia and nisoldipine pretreatment on the asymmetric distribution of phosphatidylethanolamine in a canine heart sarcolemmal preparation.
Takahashi K; Kako KJ
Biochem Med Metab Biol; 1986 Jun; 35(3):308-21. PubMed ID: 3718762
[TBL] [Abstract][Full Text] [Related]
34. Differential effect of lipid peroxidation on membrane fluidity as determined by electron spin resonance probes.
Bruch RC; Thayer WS
Biochim Biophys Acta; 1983 Sep; 733(2):216-22. PubMed ID: 6309228
[TBL] [Abstract][Full Text] [Related]
35. Recent insights pertaining to sarcolemmal phospholipid alterations underlying arrhythmogenesis in the ischemic heart.
McHowat J; Yamada KA; Wu J; Yan GX; Corr PB
J Cardiovasc Electrophysiol; 1993 Jun; 4(3):288-310. PubMed ID: 8269301
[TBL] [Abstract][Full Text] [Related]
36. Vitamin E supplement improves erythrocyte membrane fluidity of thalassemia: an ESR spin labeling study.
Sutipornpalangkul W; Morales NP; Unchern S; Sanvarinda Y; Chantharaksri U; Fucharoen S
J Med Assoc Thai; 2012 Jan; 95(1):29-36. PubMed ID: 22379738
[TBL] [Abstract][Full Text] [Related]
37. Lysophosphatidylcholine accumulation in the ischemic canine heart.
Kinnaird AA; Choy PC; Man RY
Lipids; 1988 Jan; 23(1):32-5. PubMed ID: 3352470
[TBL] [Abstract][Full Text] [Related]
38. Phospholipid composition and amphiphile content of isolated sarcolemma from normal and autolytic rat myocardium.
Suyatna FD; van Veldhoven PP; Borgers M; Mannaerts GP
J Mol Cell Cardiol; 1988 Jan; 20(1):47-62. PubMed ID: 3367378
[TBL] [Abstract][Full Text] [Related]
39. Effects of platelet-activating factor (PAF), lyso-PAF and lysophosphatidylcholine on phosphatidylcholine bilayers, an ESR, 31P-NMR and X-ray diffraction study.
Olivier JL; Chachaty C; Quinn PJ; Wolf C
J Lipid Mediat; 1991; 3(3):311-32. PubMed ID: 1663404
[TBL] [Abstract][Full Text] [Related]
40. Change in membrane lipid fluidity induced by phospholipase A activation: a mechanism of endotoxic shock.
Liu MS; Ghosh S; Yang Y
Life Sci; 1983 Nov; 33(20):1995-2002. PubMed ID: 6358754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
